Biochemical prognostic markers of outcome in non-paracetamol-induced fulminant hepatic failure.

@article{Dabos2004BiochemicalPM,
  title={Biochemical prognostic markers of outcome in non-paracetamol-induced fulminant hepatic failure.},
  author={Konstantinos John Dabos and Philip N Newsome and John A. Parkinson and Hazem H Mohammed and Ian Howard Sadler and J N Plevris and Peter C Hayes},
  journal={Transplantation},
  year={2004},
  volume={77 2},
  pages={
          200-5
        }
}
  • Konstantinos John Dabos, Philip N Newsome, +4 authors Peter C Hayes
  • Published in Transplantation 2004
  • Medicine
  • BACKGROUND Fulminant hepatic failure (FHF) is associated with major metabolic disturbances, the onset and severity of which can predict clinical outcome. This study uses admission blood samples to identify early biochemical markers of clinical outcome in patients with non-paracetamol-induced FHF. PATIENTS AND METHODS Fifty-nine patients admitted to the Scottish Liver Transplant Unit with non-paracetamol-induced FHF were studied. Plasma samples were collected at a median of 5.4 hr after… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 14 CITATIONS

    Regional variations in the concentrations of ketone bodies in cirrhosis and hepatic encephalopathy: a study in patients with TIPSS.

    VIEW 1 EXCERPT
    CITES METHODS

    Increase brain lactate in hepatic encephalopathy: Cause or consequence?

    VIEW 1 EXCERPT
    CITES BACKGROUND